---
figid: PMC6909887__glz056f0001
figtitle: Mechanistic Target Of Rapamycin Complex 1 (mTORC1) signaling pathway with
  areas of potential pharmaceutical inhibition highlighted
organisms:
- Homo sapiens
- Canis lupus familiaris
pmcid: PMC6909887
filename: glz056f0001.jpg
figlink: pmc/articles/PMC6909887/figure/F1/
number: F1
caption: 'An overview of the mechanistic Target Of Rapamycin Complex 1 (mTORC1) signaling
  pathway with areas of potential pharmaceutical inhibition highlighted. Negative
  regulators (CASTOR1, GATOR1, SAMTOR, Sestrin2, tuberous sclerosis complex [TSC])
  and positive regulators (FLCN-FNIP2, GATOR2, KICKSTOR, LRS, RAG GTPases, RAGULATOR,
  Rheb, SLC38A9, v-ATPase) are shown. Potential mechanisms for the development of
  mTORC1 specific inhibitors include: A, B, C, D. Identifying small molecules that
  block the ability of amino acid sensors upstream of mTORC1 to sense the availability
  of leucine, arginine, or SAM; (E, F) developing compounds such as BC-LI-0186 that
  inhibit the GAP or GEF activities of FLCN-FNIP2, LRS, or RAGULATOR; (G) Inhibiting
  the interaction of mTORC1 and Rheb, the mechanism of action of NR1; and (H) Identifying
  rapamycin derivatives that specifically inhibit mTORC1. Figure is adapted from (),
  doi:10.1242/dev.152595, with permission from The Company of Biologists Ltd.'
papertitle: Next Generation Strategies for Geroprotection via mTORC1 Inhibition.
reftext: Sabrina N Dumas, et al. J Gerontol A Biol Sci Med Sci. 2020 Jan;75(1):14-23.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8909568
figid_alias: PMC6909887__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Canis lupus familiaris
redirect_from: /figures/PMC6909887__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6909887__glz056f0001.html
  '@type': Dataset
  description: 'An overview of the mechanistic Target Of Rapamycin Complex 1 (mTORC1)
    signaling pathway with areas of potential pharmaceutical inhibition highlighted.
    Negative regulators (CASTOR1, GATOR1, SAMTOR, Sestrin2, tuberous sclerosis complex
    [TSC]) and positive regulators (FLCN-FNIP2, GATOR2, KICKSTOR, LRS, RAG GTPases,
    RAGULATOR, Rheb, SLC38A9, v-ATPase) are shown. Potential mechanisms for the development
    of mTORC1 specific inhibitors include: A, B, C, D. Identifying small molecules
    that block the ability of amino acid sensors upstream of mTORC1 to sense the availability
    of leucine, arginine, or SAM; (E, F) developing compounds such as BC-LI-0186 that
    inhibit the GAP or GEF activities of FLCN-FNIP2, LRS, or RAGULATOR; (G) Inhibiting
    the interaction of mTORC1 and Rheb, the mechanism of action of NR1; and (H) Identifying
    rapamycin derivatives that specifically inhibit mTORC1. Figure is adapted from
    (), doi:10.1242/dev.152595, with permission from The Company of Biologists Ltd.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - TNF
  - CASTOR1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LARS1
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - RRAGC
  - RRAGD
  - MTOR
  - RPTOR
  - RRAGA
  - RRAGB
  - BMT2
  - MTG1
  - RHEB
  - RHEBP1
  - SLC38A9
  - DNAH8
  - Leucine
  - Arginine
  - Methionine
  - GDP
  - Energy Stress
---
